Epigenomics and immunotherapeutic advances in pediatric brain tumors
Abstract Brain tumors are the leading cause of childhood cancer-related deaths. Similar to adult brain tumors, pediatric brain tumors are classified based on histopathological evaluations. However, pediatric brain tumors are often histologically inconsistent with adult brain tumors. Recent research...
Guardado en:
Autores principales: | Malak Abedalthagafi, Nahla Mobark, May Al-Rashed, Musa AlHarbi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b0ded3fd249f44f186613b5be1f73850 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
Publicado: (2021) -
Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
por: Hua Zhao, et al.
Publicado: (2021) -
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
por: Feng Liu, et al.
Publicado: (2017) -
Global molecular alterations involving recurrence or progression of pediatric brain tumors
por: Fengju Chen, et al.
Publicado: (2022) -
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
por: Pauline Thomas, et al.
Publicado: (2021)